Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
STRIDE program examined potential treatment targets for inflammatory bowel disease. The group agreed upon 12 recommendations for ulcerative colitis (UC) and Crohn's disease (CD) The agreed target for UC was clinical/patient-reported outcome remission
